Are you a media representative looking for content on Bayer? This section provides news, press photos and more.
News
May 19, 2026
Not intended for U.S. and UK Media
New drug applications for Bayer’s FXIa inhibitor accepted by U.S. Food and Drug Administration under Priority Review and by Japan’s Ministry of Health, Labour and Welfare
May 18, 2026
Not intended for U.S. and UK Media
FDA grants sevabertinib Priority Review as a first-line treatment for patients with HER2-mutant non-small cell lung cancer
May 12, 2026
First quarter of 2026:
Bayer reports solid start to the year and confirms currency-adjusted Group guidance for 2026
In Focus
Our Services
Publications
Get easy access to the different reports, magazines and brochures from Bayer.
Publikationen
Discover more
